🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
Summary In patients with prostate cancer (PC) who have only biochemically ...
Status
Unknown
Location
Copenhagen University hospital, Rigshospitalet
Start Date
2009-02
Trial ID
NCT03119857
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2004-07
Trial ID
NCT00085332
Treatments Being Tested
Currently, for further improved survival outcome, new cytotoxic compounds s...
Status
Completed
Location
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Start Date
2013-07
Trial ID
NCT02495493
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Institut Jules Bordet
Start Date
1999-07
Trial ID
NCT00004884
Treatments Being Tested
This study is determining the maximum tolerated dose and safety of SU011248...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-07
Trial ID
NCT00712504
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
This is a feasibility study evaluating the use of a mathematical model to p...
Status
Completed
Location
University of New Mexico Comprehensive Cancer Center
Start Date
2015-06-02
Trial ID
NCT03983538
Treatments Being Tested
This study is a Phase III non-inferiority trial targeting a specific subset...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07432178
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955